Literature DB >> 343606

An areawide survey of treated end-stage renal disease.

J S Mausner, J K Clark, B I Coles, H Menduke.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 343606      PMCID： PMC1653876          DOI： 10.2105/ajph.68.2.166

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  12 in total

1.  An epidemiologic study of renal failure. I. The need for maintenance hemodialysis.

Authors:  B Modan; H Boichis; G Bott-Kanner; V Barell; N Bar-Noach; H E Eliahou
Journal:  Am J Epidemiol       Date:  1975-04       Impact factor: 4.897

2.  Individual differences in selecting patients for regular haemodialysis.

Authors:  T R Taylor; J Aitchison; L S Parker; M F Moore
Journal:  Br Med J       Date:  1975-05-17

3.  Methodological problems in the estimation of maintenance dialysis needs.

Authors:  B Modan; V Leslau; G Bott-Kanner; N Barnoach; H E Eliahou
Journal:  Int J Epidemiol       Date:  1972       Impact factor: 7.196

4.  Prevalence of chronic renal failure and access to dialysis.

Authors:  M McCormick; V Navarro
Journal:  Int J Epidemiol       Date:  1973       Impact factor: 7.196

5.  Requirements for the treatment of terminal uremia in a Danish population of one million.

Authors:  T Pindborg; J Rojel; H R Sorensen; E Kemp
Journal:  Scand J Urol Nephrol       Date:  1973

6.  Survey of chronic renal failure in Scotland.

Authors:  D M Pendreigh; L F Howitt; A J Macdougall; J S Robson; M A Heasman; A C Kennedy; M MacLeod; W K Stewart
Journal:  Lancet       Date:  1972-02-05       Impact factor: 79.321

7.  Chronic renal failure in Northern Ireland, 1968-70. A prospective survey.

Authors:  M G McGeown
Journal:  Lancet       Date:  1972-02-05       Impact factor: 79.321

8.  Estimating the need for facilities for renal dialysis.

Authors:  L Lipworth
Journal:  Public Health Rep       Date:  1968-08       Impact factor: 2.792

9.  Characteristics of Connecticut patients receiving services for end-stage uremia.

Authors:  D A Pearson; T J Stranova; J D Thompson
Journal:  Public Health Rep       Date:  1975 Sep-Oct       Impact factor: 2.792

10.  Incidence of uraemia and requirements for maintenance haemodialysis.

Authors:  R A Branch; G W Clark; A L Cochrane; J H Jones; H Scarborough
Journal:  Br Med J       Date:  1971-01-30
View more
  11 in total

1.  The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980-85.

Authors:  R Ferguson; C E Grim; T J Opgenorth
Journal:  Am J Public Health       Date:  1987-07       Impact factor: 9.308

2.  End-stage renal disease in blacks: a national or international problem?

Authors:  M G Dillard; C O Callender
Journal:  J Natl Med Assoc       Date:  1984-12       Impact factor: 1.798

3.  Epidemiologic features of treated end-stage renal disease in a large prepaid health plan.

Authors:  J D Ordonez; R A Hiatt; C P Quesenberry
Journal:  Am J Public Health       Date:  1990-01       Impact factor: 9.308

4.  Characteristics of patients referred for treatment of end-stage renal disease in a defined population.

Authors:  R A Hiatt; G D Friedman
Journal:  Am J Public Health       Date:  1982-08       Impact factor: 9.308

5.  The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.

Authors:  C Lucas; P Jenkins; J Mendels; D Due; W P Forbes; M A Sirgo
Journal:  J Natl Med Assoc       Date:  1991-10       Impact factor: 1.798

6.  The incidence of treated end stage renal disease in the eastern United States: 1973-1979.

Authors:  T Sugimoto; S J Rosansky
Journal:  Am J Public Health       Date:  1984-01       Impact factor: 9.308

Review 7.  End-stage renal disease and race: an overview and perspective.

Authors:  R Ferguson
Journal:  J Natl Med Assoc       Date:  1991-09       Impact factor: 1.798

8.  Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children.

Authors:  E Ingulli; A Tejani
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

9.  The impact of heroin abuse on a regional end-stage renal disease program.

Authors:  M A Zielezny; E E Cunningham; R C Venuto
Journal:  Am J Public Health       Date:  1980-08       Impact factor: 9.308

10.  The Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival.

Authors:  P W Eggers; R Connerton; M McMullan
Journal:  Health Care Financ Rev       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.